510(k) K152155

ARCHITECT 2nd Generation Testosterone by Abbott Laboratories — Product Code CDZ

K152155 is an FDA 510(k) premarket notification submitted by Abbott Laboratories for the device "ARCHITECT 2nd Generation Testosterone". The FDA issued a decision of Substantially Equivalent on December 17, 2015. The device falls under product code CDZ (Radioimmunoassay, Testosterones And Dihydrotestosterone), a Class I device regulated under 21 CFR 862.1680. Abbott Laboratories has at least 10 other 510(k) clearances on record.

Clearance Details

Decision
SESE (Substantially Equivalent)
Decision Date
December 17, 2015
Date Received
August 3, 2015
Clearance Type
Traditional
Expedited Review
No
Third Party Review
No

Device Classification

Device Name
Radioimmunoassay, Testosterones And Dihydrotestosterone
Device Class
Class I
Regulation Number
862.1680
Review Panel
CH
Submission Type